Eisai Launches Antiasthmatic, Antitussive and Expectorant, ASTHPHYLLIN(R) S Tablets
ASTHPHYLLIN(R) S is an OTC (over-the-counter) version of ASTHPHYLLIN(R), an antiasthmatic drug for prescription use and has been developed to fit the Japanese non-prescription drug approval standards for its therapeutic category.
ASTHPHYLLIN(R) S contains diprophylline and dl-methylephedrine hydrochloride to dilate constricted bronchial tubes and widen airways, making it easier to expectorate, in addition to noscapine which acts on the part of the central nervous system responsible for coughing, and diphenhydramine hydrochloride to relieve allergic asthma and coughing. These ingredients work together and can control coughing triggered by allergic inflammation in the mucous membranes of the respiratory tract, which is a key factor in asthma, and the nighttime coughing which is characteristic of the disease.
Most read news
Topics
Organizations
Other news from the department research and development
These products might interest you
Anopore™ by Cytiva
Precise filtration made easy with Anopore inorganic membranes
The aluminum oxide filter membrane that can increase the purity or yield of your analyte
Hahnemühle LifeScience Catalogue Industry & Laboratory by Hahnemühle
Wide variety of Filter Papers for all Laboratory and Industrial Applications
Filtration Solutions in the Life Sciences, Chemical and Pharmaceutical Sectors
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.